Clinical effects of dexamethasone among patients with sickle cell disease hospitalized with COVID-19: Outcomes from a single academic health system.
Garneau WM, Lankiewicz MJ, Lesko CR, Lauriello AP, Gebo KA, Lanzkron SM. Clinical effects of dexamethasone among patients with sickle cell disease hospitalized with COVID-19: Outcomes from a single academic health system. PLoS One. 2024; 19(11):e0313289.